Abstract
Myotonic dystrophies (DMs) are characterised by highly variable clinical manifestations consisting of muscle weakness and atrophy, and a wide spectrum of extramuscular manifestations. In both DM1 and DM2 forms, expanded nucleotide sequences cause the accumulation of mutant transcripts in the nucleus, thus deregulating the function of some RNA-binding proteins and providing a plausible explanation for the multifactorial phenotype of DM patients. However, at the skeletal muscle level, no mechanistic explanation for the muscle wasting has so far been proposed. We therefore performed a study in situ by immunoelectron microscopy on biceps brachii biopsies from DM1, DM2 and healthy subjects, providing the first ultrastructural evidence on the distribution of some nuclear ribonucleoprotein (RNP)-containing structures and molecular factors involved in pre-mRNA transcription and maturation in dystrophic myonuclei. Our results demonstrated an accumulation of splicing and cleavage factors in myonuclei of both DM1 and DM2 patients, suggesting an impairment of post-transcriptional pre-mRNA pathways. The transcription of the expanded sequences in DM myonuclei would therefore hamper functionality of the whole splicing machinery, slowing down the intranuclear molecular trafficking; this would reduce the capability of myonuclei to respond to anabolic stimuli thus contributing to muscle wasting.
References
Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, Bottani A, Kohler A, Shriver MD, Sallinen R, Wessman M, Zhang S, Wright FA, Krahe R (2003) Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Gen 73:835–848
Bernhard W (1969) A new staining procedure for electron microscopic cytology. J Ultrastruct Res 27:250–265
Biggiogera M, Fakan S (2008) Visualization of nuclear organization by ultrastructural cytochemistry. Methods Cell Biol 88:431–449
Biggiogera M, Cisterna B, Spedito A, Vecchio L, Malatesta M (2008) Perichromatin fibrils as early markers of transcriptional alterations. Differentiation 76:57–65
Bigot A, Klein AF, Gasnier E, Jacquemin V, Ravassard P, Butler-Browne G, Mouly V, Furling D (2009) Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells. Am J Pathol 174:1435–1442
Bogolyubov D, Stepanova I, Parfenov V (2009) Universal nuclear domains of somatic and germ cells: some lessons from oocyte interchromatin granule cluster and Cajal body structure and molecular composition. Bioessays 31:400–409
Botta A, Caldarola S, Vallo L, Bonifazi E, Fruci D, Gullotta F, Massa R, Novelli G, Loreni F (2006) Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). Biochim Biophys Acta 1762:329–334
Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 69:385–387
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423
Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657–664
Fakan S (2004) The functional architecture of the nucleus as analysed by ultrastructural cytochemistry. Histochem Cell Biol 122:83–93. doi:10.1007/s00418-004-0681-1
Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, Brook JD (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11:805–814
Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256–1258
Giagnacovo M, Cardani R, Meola G, Pellicciari C, Malatesta M (2010) Routinely frozen biopsies of human skeletal muscle are suitable for morphological and immunocytochemical analyses at transmission electron microscopy. Eur J Histochem 54:e31
Harper PS (2001) Myotonic dystrophy, 3rd edn. WB Saunders, London
Huichalaf C, Sakai K, Jin B, Jones K, Wang GL, Schoser B, Schneider-Gold C, Sarkar P, Pereira-Smith OM, Timchenko N, Timchenko L (2010) Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells. FASEB J 24:3706–3719
Jones RE, Okamura CS, Martin TE (1980) Immunofluorescent localization of the proteins of nuclear ribonucleoprotein complexes. J Cell Biol 86:235–243
Kim W, Sharpless N (2006) The regulation of INK4/ARF in cancer and aging. Cell 127:265–275
Kimura T, Nakamori M, Lueck JD, Pouliquin P, Aoike F, Fujimura H, Dirksen RT, Takahashi MP, Dulhunty AF, Sakoda S (2005) Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet 14:2189–2200
Ladd AN, Charlet N, Cooper TA (2001) The CELF family of RNA binding proteins is implicated in cellspecific and developmentally regulated alternative splicing. Mol Cell Biol 21:1285–1296
Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864–867
Lührmann R, Kastner B, Bach M (1990) Structure of spliceosomal snRNPs and their role in pre-mRNA splicing. Biochim Biophys Acta 1087:265–292
Madhani HD, Guthrie C (1994) Dynamic RNA-RNA interactions in the spliceosome. Annu Rev Genet 28:1–26
Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barceló J, O’Hoy K, Leblond S, Earle-MacDonald J, de Jong PJ, Wieringa B, Korneluk RG (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253–1255
Malatesta M, Meola G (2010) Structural and functional alterations of the cell nucleus in skeletal muscle wasting: the evidence in situ. Eur J Histochem 54:e44
Malatesta M, Baldelli B, Battistelli S, Fattoretti P, Bertoni-Freddari C (2005) Aging affects the distribution of the circadian CLOCK protein in rat hepatocytes. Microsc Res Tech 68:45–50
Malatesta M, Fattoretti P, Baldelli B, Battistelli S, Balietti M, Bertoni-Freddari C (2007) Effects of ageing on the fine distribution of the circadian CLOCK protein in reticular formation neurons. Histochem Cell Biol 127:641–647
Malatesta M, Perdoni F, Muller S, Zancanaro C, Pellicciari C (2009) Nuclei of aged myofibres undergo structural and functional changes suggesting impairment in RNA processing. Eur J Histochem 53:97–106
Malatesta M, Biggiogera M, Cisterna B, Balietti M, Bertoni-Freddari C, Fattoretti P (2010a) Perichromatin fibrils accumulation in hepatocyte nuclei reveals alterations of pre-mRNA processing during ageing. DNA Cell Biol 29:49–57
Malatesta M, Perdoni F, Muller S, Pellicciari C, Zancanaro C (2010b) Pre-mRNA processing is partially impaired in satellite cell nuclei from aged muscles. J Biomed Biotechnol 2010:410405
Margolis JM, Schoser BG, Moseley ML, Day JW, Ranum LP (2006) DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum Mol Genet 15:1808–1815
Meola G (2005) Advanced microscopic and histochemical techniques: diagnostic tools in the molecular era of myology. Eur J Histochem 49:93–96
Meola G, Moxley RT 3rd (2004) Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 251:1173–1182
Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 19:4439–4448
Mulders SAM, van den Broek WJAA, Wheeler TM, Croes HJE, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, Wieringa B, Wansink DG (2009) Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc Natl Acad Sci USA 106:13915–13920
Osborne RJ, Thornton CA (2006) RNA-dominant diseases. Hum Mol Genet 15:R162–R169
Perdoni F, Malatesta M, Cardani R, Giagnacovo M, Mancinelli E, Meola G, Pellicciari C (2009) RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study. Eur J Histochem 53:151–158
Puvion E, Puvion-Dutilleul F (1996) Ultrastructure of the nucleus in relation to transcription and splicing: roles of perichromatin fibrils and interchromatin granules. Exp Cell Res 229:217–225
Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW (1998) Genetic mapping of a second myotonic dystrophy locus. Nat Genet 19:196–198
Salisbury E, Sakai K, Schoser B, Huichalaf C, Schneider-Gold C, Nguyen H, Wang GL, Albrecht JH, Timchenko LT (2008) Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1. Exp Cell Res 314:2266–2278
Salisbury E, Schoser B, Schneider-Gold C, Wang GL, Huichalaf C, Jin B, Sirito M, Sarkar P, Krahe R, Timchenko NA, Timchenko LT (2009) Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients. Am J Pathol 175:748–762
Savkur RS, Philips AV, Cooper TA (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29:40–47
Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, Day JW (2004) Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74:1309–1313
Schoser B, Timchenko L (2010) Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. Curr Genomics 11:77–90
Tews DS, Goebel HH (2005) Diagnostic immunohistochemistry in neuromuscular disorders. Histopathology 46:1–23
Thompson LD (2009) Age-related muscle dysfunction. Exp Gerontol 44:106–111
Timchenko NA, Iakova P, Cai ZJ, Smith JR, Timchenko LT (2001) Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 21:6927–6938
Timchenko NA, Patel R, Iakova P, Cai ZJ, Quan L, Timchenko LT (2004) Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 279:13129–13139
Veraldi KL, Arhin GK, Martincic K, Chung-Ganster LH, Wilusz J, Milcarek C (2001) HnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol Cell Biol 21:1228–1238
Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforêt P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B (2003) Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 60:1854–1857
Wahle E, Rüegsegger U (1999) 3′-end processing of pre-mRNA in eukaryotes. FEMS Microbiol Rev 23:277–295
Warf MB, Nakamori M, Matthys CM, Thornton CA, Berglund JA (2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc Natl Acad Sci USA 106:18551–18556
Wheeler TM, Thornton CA (2007) Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol 20:572–576
Acknowledgments
We express our gratitude to Prof. T.E. Martin for kindly providing us with the anti-hnRNP core protein antibody. Marzia Giagnacovo is a PhD student in receipt of a fellowship from the Dottorato di Ricerca in Biologia Cellulare (University of Pavia).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Malatesta, M., Giagnacovo, M., Cardani, R. et al. RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy. Histochem Cell Biol 135, 419–425 (2011). https://doi.org/10.1007/s00418-011-0797-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-011-0797-z